World supplier of antibodies, antigens and kits since 2007
Signal Inhibitors and Activators

DCC-2036

$1118.4/ 10mg1​ PHYSICAL AND CHEMICAL PROPERTIES
Quantity
Total: $1118

Ship worldwide. Contact order@enogene.com for ordering and bulk pricing or contact your local distributor.

Product Information

Kinase Inhibitor Name DCC-2036
FormulaC30H28FN7O3
SolubilityDMSO ≥111 mg/mL   Water <1 mg/mL   Ethanol ≥16 mg/mL
Stability:
2 years       -20℃     Powder
1 week        -4℃     in DMSO
1 month     -80℃     in DMSO
CAS No.1020172-07-9
M.W.553.59
Price1118.4$
Research AreaStem Cells Cancer Cardiovascular Cell Biology Epigenetics & Nuclear Signaling Developmental Biologys Immunology Drug Discovery Products Metabolism Neuroscience Signal Transduction
an ABL switch control inhibitor with IC50 of 0.8 and 2 nM for respectively. DCC-2036 strongly prevents both unphosphorylated and a type II inactive conformation, and retains efficacy against the majority mutants, including T315I. DCC-2036 suppresses BCR-ABL1(T315I)-expressing survival in mouse models of T315I mutant CML and B-lymphoblastic patient leukemia cells expressing T315I in vitro and in vivo, supporting
an ABL switch control inhibitor with IC50 of 0.8 and 2 nM for respectively. DCC-2036 strongly prevents both unphosphorylated and a type II inactive conformation, and retains efficacy against the majority mutants, including T315I. DCC-2036 suppresses BCR-ABL1(T315I)-expressing survival in mouse models of T315I mutant CML and B-lymphoblastic patient leukemia cells expressing T315I in vitro and in vivo, supporting